Loading...

EVH EVOLENT HEALTH INC Investor Conferences 8-K Filing

VLNT

VH

EVOLENT HEALTH INC

(EVH)

2025 8-K

Financial Results Report

Stock Purchase Completed

Leadership Restructuring

Financial Guidance Reaffirmed

Convertible Notes Issued

Convertible Notes Offering

Debt Offering Announcement

Financial Statements

Debt Restructuring

Elections of Directors

Financial Statements

Financial Results

Credit Agreement Amendment

Investor Presentation

Credit Agreement Amendment

Financial Results

Earnings Report

Annual Meeting Voting Results

Acquisition of Assets

Earnings Report

Earnings Report

Management Changes

Earnings Guidance

Material Definitive Agreement

Offering of Convertible Sen...

Earnings Report

Amendment to Financial Results

Financial Results and Redem...

Appointment of Dr. Toyin Aj...

Annual Meeting of Stockholders

Regulation FD Disclosure

Financial Results and Depar...

Departure of Directors

Termination of Agreement

Financial Results Announcement

Annual Meeting Date Set

Acquisition and Financing

Results of Operations and F...

External Links:

On June 3, 2025, Evolent Health, Inc. presented at the William Blair 45th Annual Growth Stock Conference, reaffirming its 2025 revenue guidance of $2.06 billion to $2.11 billion and Adjusted EBITDA of $135 million to $165 million.

AI Assistant

EVOLENT HEALTH INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.